Navigation Links
Kensey Nash Corporation Announces Achievement of $6 Million Milestone From Spectranetics Corporation

EXTON, Pa., Dec. 12, 2011 /PRNewswire/ -- Kensey Nash Corporation (Nasdaq: KNSY) today announced that it was recently informed by Spectranetics Corporation (Nasdaq: SPNC) that they reached a cumulative $20 million in end-user sales of the endovascular product lines purchased from Kensey Nash in May 2008. Accordingly, this triggered achievement of a $6 million milestone payable to Kensey Nash.  As previously disclosed, the Company expects to record approximately $5 million as revenue for the three months ending December 31, 2011, and the remainder will be deferred and recognized as revenue over the next year. The $6 million cash payment is expected to be received in February 2012.

About Kensey Nash Corporation.  Kensey Nash Corporation is a medical device company primarily focused on regenerative medicine utilizing its proprietary collagen and synthetic polymer technologies.  The Company is recognized as a leader for innovative product development and unique technology in the field of resorbable biomaterials.  The Company has an extensive range of products which are sold through strategic partners in multiple medical markets, including the cardiology, orthopaedic, sports medicine, spine, endovascular and general surgery markets.  For more information, visit

SOURCE Kensey Nash Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. Kensey Nash Reports Second Quarter Fiscal Year 2011 Financial Results
2. Kensey Nash to Present at the 2009 UBS Global Life Sciences Conference
3. Synthes and Kensey Nash Announce Strategic Agreement for Extracellular Matrix Products
4. Kensey Nash Announces Agreement to Acquire Rights to OsseoFit Product
5. Kensey Nash Reports Strong Second Quarter and First Six Month Fiscal Year 2009 Results
6. Kensey Nash Reports Fourth Quarter and Fiscal Year 2008 Results
7. China Cord Blood Corporation to Report Second Quarter and First Half of Fiscal 2012 Financial Results
8. United Therapeutics Corporation Reports Third Quarter 2011 Financial Results
9. United Therapeutics Corporation to Announce Third Quarter 2011 Financial Results Before Market Open on Thursday, October 27, 2011
10. China Cord Blood Corporation to Hold Annual General Meeting in Hong Kong on December 19, 2011
11. Luminex Corporation Joins Forces With the National Marrow Donor Program - Be The Match®
Post Your Comments:
(Date:12/1/2015)... Calif. , Dec. 1, 2015 Cepheid ... of its participation at the Piper Jaffray Healthcare Conference ... this morning, the Company is reaffirming its outlook for ... for 2016, in addition to discussing longer term business ... and Chief Executive Officer.  "We continue to be the ...
(Date:12/1/2015)... ... 01, 2015 , ... The American Society of Gynecologic Laparoscopists, ... Mathews will join fellow surgeons in the shared pursuit of “advancing minimally ... urogynecologist, founder of Plano Urogynecology Associates and Fellow of the American College ...
(Date:12/1/2015)... DUBLIN , December 1, 2015 /PRNewswire/ ... the addition of the  "2016 U.K. Virology ... Segment Forecasts for 100 Tests, Supplier Shares ... Opportunities"  report to their offering.  --> ... of the  "2016 U.K. Virology and Bacteriology ...
(Date:11/30/2015)... ... ... Global Stem Cells Group announced that its scientific team is ... adipose-derived stem cells. The announcement starts a new phase toward launching the simple, quick ... of the lipoaspirate obtained from liposuction of excess adipose tissue. , Lipoaspirate, contains ...
Breaking Biology Technology:
(Date:11/17/2015)... , November 17, 2015 ... au 19 novembre  2015.  --> Paris ... --> DERMALOG, le leader de l,innovation biométrique, ... la fois passeports et empreintes sur la même surface ... les passeports et l,autre pour les empreintes digitales. Désormais, ...
(Date:11/16/2015)... , Nov 16, 2015  Synaptics Inc. ... human interface solutions, today announced expansion of its ... ™ touch controller and display driver integration ... of smartphones. These new TDDI products add to ... (HD resolution), TD4302 (WQHD resolution), and TD4322 (FHD ...
(Date:11/12/2015)... 2015   Growing need for low-cost, easy ... been paving the way for use of biochemical ... analytes in clinical, agricultural, environmental, food and defense ... in medical applications, however, their adoption is increasing ... continuous emphasis on improving product quality and growing ...
Breaking Biology News(10 mins):